Navigation Links
Gastroenterologists Unlikely To Use Celltrion/Hospira's Infliximab Biosimilar Due To Lack Of Clinical Data In Inflammatory Bowel Disease
Date:9/30/2013

EXTON, Penn., Sept. 30, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that the majority of surveyed gastroenterologists do not expect to prescribe an infliximab biosimilar, such as Celltrion's Remsima, in their Crohn's disease (CD) or ulcerative colitis (UC) patients that has not been clinically tested in inflammatory bowl diseases.

The Biosimilars Advisory Service report entitled Physician Perspectives on Pegylated IFN-a and TNF-a Inhibitors in Immune and Infectious Disease provides analysis of survey results from over 90 gastroenterologists, as well as more than 90 rheumatologists in the United States and Europe. The report finds that over 70 percent of surveyed gastroenterologists would not use biosimilar infliximab in CD or UC patients if the clinical trial had only been conducted in rheumatoid arthritis patients. Only a minority of survey respondents believe that indication extrapolation is an overall good idea.

The report also finds that surveyed rheumatologists are similarly cautious about indication extrapolation, but most biosimilars of TNF-alpha inhibitors under development are being studied in rheumatoid arthritis patients. This strategy by biosimilar manufacturers could help to alleviate rheumatologists' concerns about prescribing these biosimilar TNF-alpha inhibitors, but this study also reveals that rheumatologists would prefer a longer treatment duration and more patients to be included in biosimilar clinical trials compared with their gastroenterology counterparts. 

"The concept of indication extrapolation is particularly relevant to prescribers of TNF-alpha inhibitors because of the breadth of indications that these biolog
'/>"/>

SOURCE BioTrends Research Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Local Gastroenterologists First in South Florida to Offer Fecal Transplant
2. The Majority of Surveyed Gastroenterologists in the EU5 Identify Remicade as Their Most Preferred Biologic for the Treatment of Ulcerative Colitis
3. The Midwest Prepares to Tackle Gnats with an Unlikely Weapon
4. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
5. Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production
6. Novation Supports New Development in the U.S. Biosimilar Pharmaceuticals Market
7. ASBM Survey Reveals Key Safety Concern Associated with Biosimilar Naming; Urges Distinct Naming Requirement
8. Reliance Pharmaceuticals: Biosimilars Company Analysis
9. Oncobiologics and Boston Oncology Team Up to Deliver Biosimilar Therapies for Cancer and Immune Disease to Middle East and North African Markets
10. Ground Zero Pharmaceuticals, Inc. (GZP) Announces Enhanced Biosimilars and Personalized Medicine Initiatives for its Clients
11. Active Pharmaceutical Ingredients (API) Market in the Americas to 2017 - Shift Towards Generics and Biosimilars as South and Central America Emerges as a Key Growth Region
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015  Two ... increasing in applications as their effectiveness is ... Kalorama Information.  Kalorama Information says that while ... the most powerful tool in proteomic biomarker ... MS) through its traditional techniques has struggled ...
(Date:2/26/2015)... Ill. , Feb. 26, 2015  AbbVie ... 15 abstracts of studies in its neuroscience and ... during the 67 th American Academy of ... , from April 18-25. The accepted abstracts ... DUOPA, in addition to investigational treatments in AbbVie,s ...
(Date:2/26/2015)... 26, 2015  Mail-service and specialty pharmacies will ... and government health plans $23.3 billion over the ... Pharmaceutical Care Management Association (PCMA). "Home ... of the easiest ways to reduce health costs," ... . "Policymakers should resist efforts to restrict these ...
Breaking Medicine Technology:Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2
(Date:2/27/2015)... 27, 2015 Legislation passed today ... a pharmacy provision to help prevent inappropriate prescriptions ... counter. The Protecting the Integrity of Medicare Act ... Chairman Kevin Brady (R-TX) and Ranking Member Jim ... prescription drug abuse epidemic and implement the right ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 The winter season ... growth and expansion. When mold grows, it can be harmful ... sure to avoid the consequences of mold growth with the ... Island, is offering tips on the best ways to prevent ... season, which makes perfect conditions for mold to thrive. Mold ...
(Date:2/27/2015)... 2015 FACE Skincare~Medical~Wellness, a multiaward-winning ... a unique combination to take fifteen years off ... is a new treatment introduced that is the ... indicated to improve lines and wrinkles on the ... who suffers from the stubborn vertical lines between ...
(Date:2/27/2015)... February 27, 2015 The UC Davis ... expertise have made it a beacon of hope for ... has been acknowledged by the national society committed to ... Huntington’s Disease Society of America — as a Level ... acknowledgement recognizes the center’s service to over 300 families ...
(Date:2/27/2015)... Healthpointe is now performing arthroscopy ... or diseases affecting the elbow , wrist ... throughout Southern California, and are dedicated in providing ... related to the upper extremities. , Dr. ... board-certified and fully trained in treating an array ...
Breaking Medicine News(10 mins):Health News:PCMA Statement on the ‘Protecting the Integrity of Medicare Act’ 2Health News:Enviro-Test Offers Tips for Winter Mold Prevention 2Health News:Face Skincare Announces New Combination Therapy 2Health News:UC Davis Huntington's Disease Center Receives Level 1 Designation 2Health News:UC Davis Huntington's Disease Center Receives Level 1 Designation 3Health News:Healthpointe is Now Performing Arthroscopic Surgery Techniques for Elbow, Hand and Wrist Injuries and Diseases, such as certain Ganglion Cysts 2
... is available in <A HREF=",http://chinese.eurekalert.org/zh/emb_releases/2009-06/oup-wfc060109.php,">Chinese . ... transform into pluripotent stem cells cells that, like ... type of cell in the body. It is the ... achieved using somatic cells (cells that are not sperm ...
... June 2 Beckman Coulter, Inc. (NYSE: BEC ... simplify, automate, and innovate complex biomedical tests, announces upcoming investor ... http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ) , , , ... - The American Association for, ...
... CASHIERS, N.C., June 2 Typical ninth graders are worried about ... friends from middle school, or keeping up with the latest popular ... the next or other mobility issues. But Luis Magana is not ... , Although Magana was diagnosed with brain cancer almost four years ...
... to regain lost trust , TUESDAY, June 2 (HealthDay News) ... criticized for not informing the public about its inner workings, ... study how to be more transparent. , "This is ... make FDA and its processes more transparent to the public," ...
... Guests ... a unique weekend series of special events and seminars with expert panels and educative discussions ... Scottsdale, Ariz. (Vocus) -- ... for the first time ever to offer a weekend retreat focused on health and wellness. ...
... (NMI), a global leader in payment gateway technologies, announced its ... Schaumburg,s Children,s Home & Aid Family Center. , , ... said NMI,s CEO Jim McKenzie. "Children,s Home & Aid is ... chance can benefit," McKenzie added. , ...
Cached Medicine News:Health News:World first: Chinese scientists create pig stem cells 2Health News:World first: Chinese scientists create pig stem cells 3Health News:Upcoming Investor Events at The American Association for Clinical Chemistry (AACC) Annual Meeting & Clinical Lab Exposition 2Health News:The SCOOTER Store Donates Scooter to North Carolina Student With Brain Cancer 2Health News:The SCOOTER Store Donates Scooter to North Carolina Student With Brain Cancer 3Health News:FDA to Study Ways to Be More Open With Public 2Health News:FDA to Study Ways to Be More Open With Public 3Health News:The Westin Kierland Resort And Mayo Clinic Present "Well Beyond" Weekend 2Health News:The Westin Kierland Resort And Mayo Clinic Present "Well Beyond" Weekend 3Health News:The Westin Kierland Resort And Mayo Clinic Present "Well Beyond" Weekend 4Health News:Network Merchants, Inc (NMI) Founders Donate $50,000 to Schaumburg's Children's Home & Aid 2
The °CureWrap is one-piece garment offers maximum available surface coverage, while avoiding the sterilized fields of operation....
... Antibody (IgG) Test is a semiquantitative enzyme ... significant IgG antibodies to M. pneumoniae between ... test should not be used for specimens ... (IgM) Test and is not intended for ...
... Test is a qualitative enzyme immunoassay ... Epstein-Barr virus capsid antigen (EBV-VCA), Epstein-Barr ... and Toxoplasma. When used in conjunction ... aid in the serodiagnosis of infectious ...
... Test is an enzyme immunoassay ... the presence of antibodies to ... and herpes simplex virus in ... to indicate previous or current ...
Medicine Products: